Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors.Pflug, A., Gaudon, S., Resa-Infante, P., Lethier, M., Reich, S., Schulze, W.M., Cusack, S.
(2018) Nucleic Acids Res 46: 956-971
- PubMed: 29202182
- DOI: https://doi.org/10.1093/nar/gkx1210
- Primary Citation of Related Structures:
6EUV, 6EUW, 6EUX, 6EUY, 6EVJ, 6EVK
- PubMed Abstract:
Influenza polymerase uses short capped primers snatched from nascent Pol II transcripts to initiate transcription of viral mRNAs. Here we describe crystal structures of influenza A and B polymerase bound to a capped primer in a configuration consistent with transcription initiation ('priming state') and show by functional assays that conserved residues from both the PB2 midlink and cap-binding domains are important for positioning the capped RNA. In particular, mutation of PB2 Arg264, which interacts with the triphosphate linkage in the cap, significantly and specifically decreases cap-dependent transcription. We also compare the configuration of the midlink and cap-binding domains in the priming state with their very different relative arrangement (called the 'apo' state) in structures where the potent cap-binding inhibitor VX-787, or a close analogue, is bound. In the 'apo' state the inhibitor makes additional interactions to the midlink domain that increases its affinity beyond that to the cap-binding domain alone. The comparison suggests that the mechanism of resistance of certain mutations that allow virus to escape from VX-787, notably PB2 N510T, can only be rationalized if VX-787 has a dual mode of action, direct inhibition of capped RNA binding as well as stabilization of the transcriptionally inactive 'apo' state.
European Molecular Biology Laboratory, Grenoble Outstation, 71 Avenue des Martyrs, CS 90181, 38042 Grenoble Cedex 9, France.